New Delhi: To control the dissemination of misleading claims about the treatment of COVID-19 through ayurvedic, Unani, Siddha and homeopathic drugs, the Ministry of AYUSH Wednesday instructed drug regulators to take action under provisions of the Disaster Management Act, 2005.<\/p>\n
\u201cAccordingly\u2026 it is hereby directed to all concerned regulatory authorities in the states and union territories to stop and prevent publicity and advertisement of AYUSH-related claims for COVID-19 treatment in print, TV and electronic media and take necessary action against the persons or agencies involved in contravening the relevant legal provisions and the aforesaid guidelines of NDMA,\u201d it also stated.<\/p>\n
Ads claim coronavirus cures
\nOn 28 March, Prime Minister Narendra Modi had interacted with AYUSH practitioners and said, \u201cAYUSH sector has a long tradition of keeping the nation healthy and its importance has increased manifold in the ongoing efforts to tackle COVID-19.\u201d<\/p>\n
\u201cStruggling from increasing complaints from Advertisement Standards Council of India \u2014 ad watchdog, the ministry decided to implement this measure,\u201d said a senior ministry official. \u201cSocial media is also flooded with fake products and false claims,\u201d he said.<\/p>\n